Area of research
Public Health, Environmental and Occupational Health · Infectious Diseases
Research interest
Research interests include Malaria Research and Control, Viral Infections and Outbreaks Research, Mosquito-borne diseases and control, and Vaccine Coverage and Hesitancy.
Reporting summary results in clinical trial registries: updated guidance from WHO.
A roadmap for fostering timely regulatory and ethics approvals of international clinical trials in support of global health research systems.
Improving the clinical trial environment and infrastructure: moving from global resolution to action.
National research ecosystems: protecting populations and building health security worldwide.
Identifying key randomised clinical trials that could transform clinical care and public health.
Artificial intelligence and clinical trials: a framework for effective adoption.
Tracking maturity of the enabling environment for clinical trials.
The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum.
Malaria vaccines for children: and now there are two
A WHO blueprint for action to reshape dementia research.
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.
WHO target product profiles to shape global research and development.
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community.
A blueprint for the worldwide research response to dementia.
WHO principles speed up ethical sharing of pathogen genomic data.
Can medical product development be better aligned with global needs?
Creating equity in health research to drive more and better evidence.
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
R21/Matrix-M: a second malaria vaccine?
Data sharing for novel coronavirus (COVID-19).
Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10–11 September 2019
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019.
Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016.
Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel.
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016.